Earnings History Data for Pacira BioSciences, Inc. (PCRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Pacira BioSciences, Inc.

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc. is based in New Jersey.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-11-2024	PM		PCRX	Pacira BioSciences, Inc.	758.79	0.53	0.50	0.52	Pacira BioSciences Non-GAAP EPS of $0.79 beats by $0.09, revenue of $168.6M misses by $9.43M [11/7/2024 2:35 AM]	17.68	0.01 (0.06%)	17.36	-0.31 (-1.75%)	11.16 - 35.95	434,245	470,000	303
Pacira BioSciences Non-GAAP EPS of $0.79 beats by $0.09, revenue of $168.6M misses by $9.43M [11/7/2024 2:35 AM] Pacira BioSciences Inc (PCRX) Q3 2024: Everything You Need To Know Ahead Of Earnings [Nov-05-24 07:55AM] Q3 2024 Pacira Biosciences Inc Earnings Call [2024-11-07 08:49AM] Pacira BioSciences Inc (PCRX) Q3 2024 Earnings Call Highlights: Strong Financial Position ... [2024-11-07 02:20AM] Pacira: Q3 Earnings Snapshot [Nov-06-24 04:10PM] Pacira BioSciences Reports Third Quarter 2024 Financial Results [Nov-06-24 04:00PM]
30-07-2024	AH		PCRX	Pacira BioSciences, Inc.	929.99	0.64	0.53	0.61	Pacira BioSciences Non-GAAP EPS of $0.89 beats by $0.19, revenue of $178M beats by $4.32M [7/30/2024 4:02 PM]	20.64	1.11 (5.66%)	21.50	1.96 (10.03%)	19.34 - 40.16	1,260,317	1,140,000	4,163
Pacira BioSciences Non-GAAP EPS of $0.89 beats by $0.19, revenue of $178M beats by $4.32M [7/30/2024 4:02 PM]
07-05-2024	AH		PCRX	Pacira BioSciences	1,271	0.42	0.64	0.00	Pacira BioSciences Non-GAAP EPS of $0.62, revenue of $167.11M [5/7/2024 5:29 PM]	29.57	3.06 (11.54%)	26.51	0.0 (0.00%)	25.33 - 43.81	1,780,365	450,000	15,583
Pacira BioSciences up 12% on stock buyback, Q1 top-line beat [5/8/2024 1:08 PM] Pacira BioSciences Non-GAAP EPS of $0.62, revenue of $167.11M [5/7/2024 5:29 PM]
29-02-2024	PM		PCRX	Pacira BioSciences, Inc.	1,380	0.71	0.71	0.60	Pacira BioSciences GAAP EPS of $0.54 beats by $0.15, revenue of $181.2M beats by $0.34M [2/29/2024 8:05 AM]	29.73	-0.18 (-0.60%)	0.0	0.0 (0.00%)	25.93 - 48.60	576,765	370,000	0
Pacira BioSciences Q4 2023 Earnings Preview [2/28/2024 11:58 AM] Pacira BioSciences GAAP EPS of $0.54 beats by $0.15, revenue of $181.2M beats by $0.34M [2/29/2024 8:05 AM]
02-11-2023	PM		PCRX	Pacira BioSciences, Inc.	1,310	0.52	0.65	0.42	Pacira BioSciences Non-GAAP EPS of $0.72 misses by $0.06, revenue of $163.93M misses by $9M [11/2/2023 8:04 AM]	29.19	0.88 (3.11%)	29.19	0.0 (0.00%)	26.59 - 53.32	901,564	400,000	18,553
Pacira BioSciences Q3 2023 Earnings Preview [11/1/2023 12:55 PM] Pacira BioSciences Non-GAAP EPS of $0.72 misses by $0.06, revenue of $163.93M misses by $9M [11/2/2023 8:04 AM]
02-08-2023	PM		PCRX	Pacira BioSciences, Inc.	1,670	0.61	0.59	0.34	Pacira BioSciences reports mixed Q2 earnings; updates FY23 outlook [8/2/2023 8:02 AM]	36.73	0.73 (2.03%)	37.01	1.01 (2.81%)	34.08 - 59.20	1,231,228	690,000	951
Pacira BioSciences Q2 2023 Earnings Preview [8/1/2023 1:13 PM] Pacira BioSciences reports mixed Q2 earnings; updates FY23 outlook [8/2/2023 8:02 AM]
03-05-2023	PM	8:00 AM ET (May 3)	PCRX	Pacira BioSciences, Inc.	2,140	0.32	0.40	0.45	Pacira BioSciences Non-GAAP EPS of $0.53 misses by $0.09, revenue of $160.3M beats by $0.88M [5/3/2023 8:02 AM]	43.00	-3.45 (-7.43%)	0.0	0.0 (0.00%)	35.35 - 75.16	1,560,835	710,000	0
Pacira BioSciences Q1 2023 Earnings Preview [5/2/2023 1:09 PM] Pacira BioSciences Non-GAAP EPS of $0.53 misses by $0.09, revenue of $160.3M beats by $0.88M [5/3/2023 8:02 AM]
28-02-2023	PM	8:00 AM ET (Feb 28)	PCRX	Pacira BioSciences, Inc.	1,940	0.60	0.71	0.78	Pacira BioSciences Non-GAAP EPS of $0.80 misses by $0.03, revenue of $172M misses by $1.32M [2/28/2023 8:02 AM]	42.77	1.81 (4.43%)	44.00	3.04 (7.42%)	35.35 - 82.16	1,400,463	540,000	3,013
Pacira BioSciences Q4 2022 Earnings Preview [2/27/2023 5:56 PM] Pacira BioSciences Non-GAAP EPS of $0.80 misses by $0.03, revenue of $172M misses by $1.32M [2/28/2023 8:02 AM]
03-11-2022	PM	8:00 AM ET (Nov 3)	PCRX	Pacira BioSciences, Inc.	2,400	0.42	0.40	0.53	Pacira BioSciences GAAP EPS of -$0.02 misses by $0.39, revenue of $167.5M in-line [11/3/2022 8:09 AM]	49.69	-1.29 (-2.53%)	49.00	-1.98 (-3.88%)	47.57 - 82.16	595,808	360,000	100
Pacira BioSciences Q3 2022 Earnings Preview [11/2/2022 1:44 PM] Pacira BioSciences reports Q3 earnings; reaffirms FY22 guidance [11/3/2022 8:09 AM] Pacira Biosciences posts wider-than-expected loss [11/3/2022 2:51 PM] Pacira BioSciences Reports Third Quarter 2022 Financial Results [Nov-03-22 08:00AM]
03-08-2022	PM	8:00 AM ET (Aug 3)	PCRX	Pacira BioSciences, Inc.	2,510	0.34	0.57	0.60	Pacira BioSciences Non-GAAP EPS of $0.51 misses by $0.34, revenue of $169.41M in-line [8/3/2022 8:02 AM]	57.88	1.90 (3.39%)	55.98	0.0 (0.00%)	45.05 - 82.16	647,567	390,000	3,899
Pacira BioSciences Q2 2022 Earnings Preview [8/2/2022 1:39 PM] Pacira BioSciences Non-GAAP EPS of $0.51 misses by $0.34, revenue of $169.41M in-line [8/3/2022 8:02 AM] Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference [Aug-02-22 08:00AM] Pacira BioSciences Reports Second Quarter 2022 Financial Results [Aug-03-22 08:00AM]
04-05-2022	PM	8:00 AM ET (May 4)	PCRX	Pacira BioSciences	3,381	0.45	0.74	0.00	Pacira BioSciences Non-GAAP EPS of $0.64 misses by $0.19, revenue of $158M beats by $2.92M; reaffirms FY22 guidance [5/4/2022 8:03 AM]	68.70	-4.31 (-5.90%)	73.01	0.0 (0.00%)	45.05 - 82.16	1,005,582	440,000	10,118
Pacira BioSciences Q1 2022 Earnings Preview [5/3/2022 11:42 AM] Pacira BioSciences Non-GAAP EPS of $0.64 misses by $0.19, revenue of $158M beats by $2.92M; reaffirms FY22 guidance [5/4/2022 8:03 AM] Pacira BioSciences Reports First Quarter 2022 Financial Results [May-04-22 08:00AM] Pacira (PCRX) Q1 Earnings Miss Estimates [May-04-22 09:15AM]
24-02-2022	PM	8:00 AM ET (Feb 24)	PCRX	Pacira BioSciences, Inc.	2,790	0.78	0.60	0.63	Pacira BioSciences Non-GAAP EPS of $0.97 beats by $0.14, revenue of $159.19M beats by $1.77M [2/24/2022 8:02 AM]	63.00	0.42 (0.67%)	0.0	0.0 (0.00%)	0.0 - 0.0	136,329	0	0
Pacira BioSciences Q4 2021 Earnings Preview [2/23/2022 11:28 AM] Pacira BioSciences Non-GAAP EPS of $0.97 beats by $0.14, revenue of $159.19M beats by $1.77M [2/24/2022 8:02 AM] Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results [Feb-24-22 08:00AM] Pacira (PCRX) Q4 Earnings and Revenues Beat Estimates [Feb-24-22 09:25AM]
03-11-2021	PM	8:00 AM ET (Nov 3)	PCRX	Pacira BioSciences, Inc.	2,390	0.53	0.44	0.43	Pacira BioSciences EPS beats by $0.07, misses on revenue [11/3/2021 8:11 AM]	56.40	2.76 (5.15%)	53.64	0.0 (0.00%)	45.05 - 80.00	647,412	300,000	7,291
Pacira BioSciences Q3 2021 Earnings Preview [11/2/2021 10:26 AM] Pacira BioSciences gets USPTO Notice of Allowance related to Exparel [11/2/2021 8:02 AM] Pacira BioSciences EPS beats by $0.07, misses on revenue [11/3/2021 8:11 AM] FLEXION THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flexion Therapeutics, Inc. - FLXN [Nov-02-21 06:35PM] Pacira Receives Notice of Allowance for New Patent Covering EXPAREL Composition [Nov-02-21 07:30AM] Pacira BioSciences Reports Third Quarter 2021 Financial Results [Nov-03-21 08:00AM] Pacira (PCRX) Beats Q3 Earnings Estimates [Nov-03-21 09:15AM] Pacira BioSciences, inc (PCRX) Q3 2021 Earnings Call Transcript [Nov-03-21 01:01PM] Pacira's (PCRX) Q3 Earnings Beat Estimates, Revenues Miss Mark [Nov-03-21 01:30PM]
03-08-2021	PM	8:00 AM ET (Aug 3)	PCRX	Pacira BioSciences, Inc.	2,600	0.60	0.54	-0.04	Pacira BioSciences EPS beats by $0.03, beats on revenue [8/3/2021 8:02 AM]	60.72	1.50 (2.53%)	59.22	0.0 (0.00%)	48.23 - 80.00	413,709	300,000	2,655
Pacira BioSciences Q2 2021 Earnings Preview [8/2/2021 11:31 AM] Pacira gets FDA approval of enhanced EXPAREL manufacturing process [8/2/2021 8:32 AM] Pacira BioSciences EPS beats by $0.03, beats on revenue [8/3/2021 8:02 AM] 10 Best Stocks to Buy According to John Paulson [Aug-02-21 10:26AM] Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing Process [Aug-02-21 08:00AM] Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021 [Aug-03-21 08:00AM] Pacira (PCRX) Q2 Earnings Surpass Estimates [Aug-03-21 09:15AM] Pacira BioSciences, inc (PCRX) Q2 2021 Earnings Call Transcript [Aug-03-21 06:30PM]
04-05-2021	PM	8:00 AM ET (May 4)	PCRX	Pacira BioSciences, Inc.	2,830	0.37	0.37	0.33	Pacira BioSciences EPS misses by $0.10, beats on revenue [5/4/2021 8:06 AM]	61.71	0.23 (0.37%)	61.71	0.0 (0.00%)	38.03 - 80.00	556,654	380,000	3,261
Pacira BioSciences EPS misses by $0.10, beats on revenue [5/4/2021 8:06 AM] Pacira Biosciences, Inc. to Host Earnings Call [May-04-21 06:45AM] Pacira BioSciences Reports First Quarter 2021 Financial Results and Business Update [May-04-21 08:00AM] Pacira (PCRX) Q1 Earnings Lag Estimates [May-04-21 09:15AM] Pacira BioSciences, Inc. (PCRX) Q1 2021 Earnings Call Transcript [May-04-21 02:30PM]
25-02-2021	PM	8:00 AM ET (Feb 25)	PCRX	Pacira BioSciences, Inc.	3,300	0.63	0.61	0.34	Pacira BioSciences EPS beats by $0.06, revenue in-line [2/25/2021 8:03 AM]	74.32	-4.50 (-5.71%)	78.82	0.0 (0.00%)	27.46 - 80.00	600,814	538,725	48,707
Pacira BioSciences EPS beats by $0.06, revenue in-line [2/25/2021 8:03 AM] Pacira BioSciences Q4 2020 Earnings Preview [2/24/2021 11:49 AM]
29-10-2020	PM	8:00 AM ET (Oct 29)	PCRX	Pacira BioSciences, Inc.	2,250	0.43	0.45	0.26	Pacira BioSciences EPS beats by $0.03, beats on revenue [10/29/2020 8:03 AM]	53.12	1.05 (2.02%)	52.07	0.0 (0.00%)	27.46 - 64.44	574,429	362,874	3,811

06-08-2020	PM	8:00 AM ET (Aug 6)	PCRX	Pacira BioSciences, Inc.	2,310	-0.04	-0.10	0.23	Pacira BioSciences EPS beats by $0.03, revenue in-line [8/6/2020 8:04 AM]	56.60	0.50 (0.89%)	55.15	-0.95 (-1.69%)	27.46 - 59.93	459,226	710,333	107